TCM

TCG Crossover Management Portfolio holdings

AUM $2.03B
1-Year Est. Return 373.29%
This Quarter Est. Return
1 Year Est. Return
+373.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.03B
AUM Growth
+$1.16B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$89.6M
2
+$38.9M
3
+$29.4M
4
LBRX
LB Pharmaceuticals
LBRX
+$27.6M
5
RVMD icon
Revolution Medicines
RVMD
+$20.4M

Top Sells

1
+$49M
2
+$18.5M
3
+$15.6M
4
UPB
Upstream Bio Inc
UPB
+$12.9M
5
THRD
Third Harmonic Bio
THRD
+$10.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
1
Abivax
ABVX
$9.34B
$604M 29.7%
7,111,596
+1,055,000
CGON icon
2
CG Oncology
CGON
$3.49B
$148M 7.27%
3,670,206
COGT icon
3
Cogent Biosciences
COGT
$6.1B
$97.6M 4.8%
6,798,162
-166,213
AMLX icon
4
Amylyx Pharmaceuticals
AMLX
$1.56B
$84.9M 4.17%
6,243,812
+300,000
CNTA
5
Centessa Pharmaceuticals
CNTA
$4.21B
$76.1M 3.74%
3,136,480
+245,664
TNGX icon
6
Tango Therapeutics
TNGX
$1.4B
$71.7M 3.53%
8,536,196
-2,199,804
OCUL icon
7
Ocular Therapeutix
OCUL
$2.49B
$71.5M 3.52%
6,117,232
+798,084
DNTH icon
8
Dianthus Therapeutics
DNTH
$1.85B
$66M 3.25%
1,676,624
+175,000
TRML
9
DELISTED
Tourmaline Bio
TRML
$62.7M 3.09%
1,311,783
-165,810
DYN icon
10
Dyne Therapeutics
DYN
$2.94B
$58.4M 2.87%
4,615,144
+848,484
AGIO icon
11
Agios Pharmaceuticals
AGIO
$1.62B
$57.4M 2.82%
1,430,041
+733,038
EYPT icon
12
EyePoint Pharmaceuticals
EYPT
$1.18B
$50.9M 2.5%
3,572,335
FULC icon
13
Fulcrum Therapeutics
FULC
$534M
$48.3M 2.38%
5,250,000
SVRA icon
14
Savara
SVRA
$1.19B
$44.1M 2.17%
12,362,205
RAPT icon
15
RAPT Therapeutics
RAPT
$873M
$42.2M 2.08%
1,636,275
TYRA icon
16
Tyra Biosciences
TYRA
$1.11B
$40.5M 1.99%
2,898,103
UPB
17
Upstream Bio Inc
UPB
$1.57B
$39.8M 1.96%
2,117,103
-684,660
LQDA icon
18
Liquidia Corp
LQDA
$2.79B
$38.9M 1.91%
+1,710,084
IRON icon
19
Disc Medicine
IRON
$3.46B
$30.7M 1.51%
465,257
GPCR icon
20
Structure Therapeutics
GPCR
$2.1B
$29.8M 1.46%
1,063,000
XNCR icon
21
Xencor
XNCR
$1.18B
$28.8M 1.41%
2,452,138
LBRX
22
LB Pharmaceuticals
LBRX
$441M
$27.6M 1.36%
+1,745,016
RVMD icon
23
Revolution Medicines
RVMD
$14.7B
$20.4M 1%
+436,473
ATXS icon
24
Astria Therapeutics
ATXS
$720M
$20.1M 0.99%
2,761,861
KRRO icon
25
Korro Bio
KRRO
$50.7M
$19.9M 0.98%
+416,301
1
2